scholarly journals Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain

2007 ◽  
Vol 77 (1) ◽  
pp. 211-220 ◽  
Author(s):  
T. Padro ◽  
E. Pena ◽  
M. Garcia-Arguinzonis ◽  
V. Llorente-Cortes ◽  
L. Badimon
Keyword(s):  
Smooth Muscle ◽  
Vascular Smooth Muscle ◽  
Smooth Muscle Cells ◽  
Vascular Smooth Muscle Cells ◽  
Light Chain ◽  
Myosin Light Chain ◽  
Muscle Cells ◽  
Low Density Lipoproteins ◽  
Low Density ◽  
Proteomic Profile

Uptake of aggregated low density lipoproteins by vascular smooth muscle cells

1994 ◽  
Vol 109 (1-2) ◽  
pp. 222-223
Author(s):  
E. Selinger ◽  
S.A. Brown ◽  
K.F. Klemp ◽  
J.R. Guyton
Keyword(s):  
Smooth Muscle ◽  
Vascular Smooth Muscle ◽  
Smooth Muscle Cells ◽  
Vascular Smooth Muscle Cells ◽  
Muscle Cells ◽  
Low Density Lipoproteins ◽  
Low Density

scholarly journals 2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells

2015 ◽  
Vol 309 (12) ◽  
pp. E995-E1007 ◽  
Author(s):  
Lisa Rigassi ◽  
Federica Barchiesi Bozzolo ◽  
Eliana Lucchinetti ◽  
Michael Zaugg ◽  
Jürgen Fingerle ◽  
...  
Keyword(s):  
Smooth Muscle ◽  
Vascular Smooth Muscle ◽  
Smooth Muscle Cells ◽  
Vascular Smooth Muscle Cells ◽  
Light Chain ◽  
Myosin Light Chain ◽  
Molecular Mechanisms ◽  
Muscle Cells ◽  
Myosin Phosphatase ◽  
Downstream Signaling

2-Methoxyestradiol (2-ME), a metabolite of estradiol with little affinity for estrogen receptors, inhibits proliferation of vascular smooth muscle cells; however, the molecular mechanisms underlying this effect are incompletely understood. Our previous work shows that 2-ME inhibits initiation (blocks phosphorylation of ERK and Akt) and progression (reduces cyclin expression and increases expression of cyclin inhibitors) of the mitogenic pathway and interferes with mitosis (disrupts tubulin organization). Because the RhoA/ROCK1 pathway (RhoA → ROCK1 → myosin phosphatase targeting subunit → myosin light chain) is involved in cytokinesis, herein we tested the concept that 2-ME also blocks the RhoA/ROCK1 pathway. Because of the potential importance of 2-ME for preventing/treating vascular diseases, experiments were conducted in female human aortic vascular smooth muscle cells. Microarray transcriptional profiling suggested an effect of 2-ME on the RhoA/ROCK1 pathway. Indeed, 2-ME blocked mitogen-induced GTP-bound RhoABC expression and membrane-bound RhoA, suggesting interference with the activation of RhoA. 2-ME also reduced ROCK1 expression, suggesting reduced production of the primary downstream signaling kinase of the RhoA pathway. Moreover, 2-ME inhibited RhoA/ROCK1 pathway downstream signaling, including phosphorylated myosin phosphatase targeting subunit and myosin light chain; the ROCK1 inhibitor H-1152 mimicked these effects of 2-ME; both 2-ME and H-1152 blocked cytokinesis. 2-ME also reduced the expression of tissue factor, yet another downstream signaling component of the RhoA/ROCK1 pathway. We conclude that 2-ME inhibits the pathway RhoA → ROCK1 → myosin phosphatase targeting subunit → myosin light chain, and this likely contributes to the reduced cytokinesis in 2-ME treated HASMCs.

scholarly journals Apelin Stimulates Myosin Light Chain Phosphorylation in Vascular Smooth Muscle Cells

2006 ◽  
Vol 26 (6) ◽  
pp. 1267-1272 ◽  
Author(s):  
Tatsuo Hashimoto ◽  
Minoru Kihara ◽  
Junji Ishida ◽  
Nozomi Imai ◽  
Shin-ichiro Yoshida ◽  
...  
Keyword(s):  
Smooth Muscle ◽  
Vascular Smooth Muscle ◽  
Smooth Muscle Cells ◽  
Vascular Smooth Muscle Cells ◽  
Light Chain ◽  
Myosin Light Chain ◽  
Muscle Cells ◽  
Myosin Light Chain Phosphorylation
Sign in / Sign up

Export Citation Format

Share Document